Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Fasnacht

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Cell & Developmental Biology|August 9, 2008
Conditional gp130 deficient mouse mutantsNicolas Fasnacht, Werner Müller
Immunity|February 16, 2010
Notch signaling in the immune systemFreddy Radtke, Nicolas Fasnacht, H Robson Macdonald
European Journal of Immunology|July 14, 2009
T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infectionNicolas Fasnacht, Marina C Greweling, Mariela Bollati-Fogolín, et al.
Frontiers in Oncology|May 19, 2023
Current perspectives on the management of patients with advanced <i>RET</i>-driven thyroid cancer in EuropeRossella Elisei, Enrique Grande, Michael C Kreissl, et al.
Inflammatory Bowel Diseases|December 25, 2010
Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10Marina C Pils, André Bleich, Immo Prinz, et al.
Future Oncology (London, England)|June 6, 2023
Real-world clinical profile, treatment patterns and patient-reported outcomes for thyroid cancer in JapanNaoki Fukuda, Yoshinori Tanizawa, Kenichi Nakamura, et al.
European Journal of Immunology|November 27, 2009
Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia modelMarina C Pils, Fabio Pisano, Nicolas Fasnacht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2013
Notch signaling regulates follicular helper T cell differentiationFloriane Auderset, Steffen Schuster, Nicolas Fasnacht, et al.
The Journal of Experimental Medicine|October 15, 2014
Specific fibroblastic niches in secondary lymphoid organs orchestrate distinct Notch-regulated immune responsesNicolas Fasnacht, Hsin-Ying Huang, Ute Koch, et al.
Future Oncology (London, England)|April 6, 2026
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in <i>KRAS</i> G12C NSCLCSolange Peters, Maximilian Hochmair, Kathryn C Arbour, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Cell & Developmental Biology|August 9, 2008
Conditional gp130 deficient mouse mutantsNicolas Fasnacht, Werner Müller
Immunity|February 16, 2010
Notch signaling in the immune systemFreddy Radtke, Nicolas Fasnacht, H Robson Macdonald
European Journal of Immunology|July 14, 2009
T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infectionNicolas Fasnacht, Marina C Greweling, Mariela Bollati-Fogolín, et al.
Frontiers in Oncology|May 19, 2023
Current perspectives on the management of patients with advanced <i>RET</i>-driven thyroid cancer in EuropeRossella Elisei, Enrique Grande, Michael C Kreissl, et al.
Inflammatory Bowel Diseases|December 25, 2010
Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10Marina C Pils, André Bleich, Immo Prinz, et al.
Future Oncology (London, England)|June 6, 2023
Real-world clinical profile, treatment patterns and patient-reported outcomes for thyroid cancer in JapanNaoki Fukuda, Yoshinori Tanizawa, Kenichi Nakamura, et al.
European Journal of Immunology|November 27, 2009
Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia modelMarina C Pils, Fabio Pisano, Nicolas Fasnacht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2013
Notch signaling regulates follicular helper T cell differentiationFloriane Auderset, Steffen Schuster, Nicolas Fasnacht, et al.
The Journal of Experimental Medicine|October 15, 2014
Specific fibroblastic niches in secondary lymphoid organs orchestrate distinct Notch-regulated immune responsesNicolas Fasnacht, Hsin-Ying Huang, Ute Koch, et al.
Future Oncology (London, England)|April 6, 2026
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in <i>KRAS</i> G12C NSCLCSolange Peters, Maximilian Hochmair, Kathryn C Arbour, et al.
Pageof 1